EMAIL THIS PAGE TO A FRIEND

The Journal of neuroscience : the official journal of the Society for Neuroscience

Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.


PMID 25319708

Abstract

Parenchymal oligodendrocyte progenitor cells (pOPCs) are considered the principal cell type responsible for oligodendrogenesis and remyelinaton in demyelinating diseases. Recent studies have demonstrated that neural precursor cells (NPCs) from the adult subventricular zone (SVZ) can also generate new oligodendrocytes after demyelination. However, the relative contribution of NPCs versus pOPCs to remyelination is unknown. We used in vivo genetic fate mapping to assess the behavior of each progenitor type within the corpus callosi (CCs) of mice subjected to cuprizone-induced demyelination. Nestin-CreER(T2) and Pdgfra-CreER(T2) transgenic mice were crossed with fluorescent Cre reporter strains to map the fate of NPCs and pOPCs respectively. In cuprizone-challenged mice, substantial numbers of NPCs migrated into the demyelinated CC and contributed to oligodendrogenesis. This capacity was most prominent in rostral regions adjacent to the SVZ where NPC-derived oligodendrocytes significantly outnumbered those generated from pOPCs. Sixty-two percent of all nodes of Ranvier in this region were flanked by at least one paranode generated from an NPC-derived oligodendrocyte. Remarkably, g-ratios (ratio of the axon diameter to the diameter of the axon plus myelin sheath) of myelinated axons in regions subject to significant NPC-derived remyelination were equivalent to those of unchallenged controls, and immunoelectron microscopy revealed that NPC-derived myelin was significantly thicker than that generated by pOPCs, regardless of axonal caliber. We also demonstrate that a reduced efficiency of remyelination in the caudal CC was associated with long-term impairment in the maturation of oligodendrogenic NPCs but only transient delay in pOPC differentiation. Collectively, our data define a major distinct role for NPCs in remyelination, identifying them as a key target for enhancing myelin repair in demyelinating diseases.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

08445
7-Amino-4-methyl-3-coumarinylacetic acid, BioReagent, suitable for fluorescence, ~90% (HPLC)
C12H11NO4
AV33880
Anti-CNP antibody produced in rabbit, IgG fraction of antiserum
HPA023266
Anti-CNP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA023278
Anti-CNP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
HPA023280
Anti-CNP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab3
HPA023338
Anti-CNP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab4
SAB2100458
Anti-CNP antibody produced in rabbit, affinity isolated antibody
C9743 Anti-CNPase antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB2502091
Anti-Dcx antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501666
Anti-DCX antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA029766
Anti-GPR17 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501250
Anti-GPR17 antibody produced in rabbit, affinity isolated antibody
SAB4501251
Anti-GPR17 antibody produced in rabbit, affinity isolated antibody
SAB2104172
Anti-MBP antibody produced in rabbit, affinity isolated antibody
HPA049222
Anti-MBP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
S8193 Anti-Sox10 antibody produced in rabbit, affinity isolated antibody, ammonium sulfate suspension
SAB2106297
Anti-SOX10 antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB2105400
Anti-SOX10, (N-terminal) antibody produced in rabbit, affinity isolated antibody
C9012
Bis(cyclohexanone)oxaldihydrazone
C14H22N4O2
WH0000324M1
Monoclonal Anti-APC antibody produced in mouse, clone 3E2, purified immunoglobulin, buffered aqueous solution
AMAB90556
Monoclonal Anti-NES antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0197, purified immunoglobulin, buffered aqueous glycerol solution
WH0116448M4
Monoclonal Anti-OLIG1 antibody produced in mouse, clone 2B11, purified immunoglobulin, buffered aqueous solution
SAB1405345
Monoclonal Anti-OLIG1 antibody produced in mouse, clone 3B3, purified immunoglobulin, buffered aqueous solution
SAB1408848 Monoclonal Anti-OLIG1 antibody produced in mouse, clone 3E3, purified immunoglobulin, buffered aqueous solution
SAB1408849
Monoclonal Anti-OLIG1 antibody produced in mouse, clone 2A4, purified immunoglobulin, buffered aqueous solution
1672745
Tranexamic acid, United States Pharmacopeia (USP) Reference Standard
C8H15NO2
T1810000
Tranexamic acid, European Pharmacopoeia (EP) Reference Standard
C8H15NO2
857653
trans-4-(Aminomethyl)cyclohexanecarboxylic acid, 97%
C8H15NO2